Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $180 | $196 | $217 | $237 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $17 | $15 | $4 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $61 | $61 | $47 | $65 |
| Total Curr. Assets | $249 | $275 | $279 | $306 |
| Property Plant & Equip (Net) | $31 | $33 | $35 | $36 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $2 | $18 | $2 |
| Total NC Assets | $33 | $35 | $53 | $38 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $282 | $309 | $332 | $344 |
| Liabilities | – | – | – | – |
| Payables | $5 | $11 | $6 | $7 |
| Short-Term Debt | $0 | $4 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $7 | $0 | $0 | $22 |
| Other Curr. Liab. | $19 | $32 | $40 | $33 |
| Total Curr. Liab. | $32 | $47 | $49 | $65 |
| LT Debt | $22 | $23 | $39 | $25 |
| Deferred Rev, NC | $4 | $0 | $0 | $13 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $9 | $10 | $0 |
| Total NC Liab. | $26 | $32 | $49 | $38 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $22 | $27 | $28 | $29 |
| Total Liabilities | $58 | $78 | $98 | $103 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$486 | -$472 | -$463 | -$449 |
| AOCI | $0 | -$0 | -$0 | $0 |
| Other Equity | $710 | $703 | $697 | $690 |
| Total Equity | $225 | $231 | $234 | $241 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $282 | $309 | $332 | $344 |
| Net Debt | -$158 | -$170 | -$174 | -$208 |